Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenza Rimassa

Showing results (1-10 of 338) with videos related to

Pageof 34
Sort By:
Cancers|October 23, 2020
Novel Therapies for Hepatocellular CarcinomaLorenza Rimassa
Gastroenterology & Hepatology|October 27, 2018
Drugs in Development for Hepatocellular CarcinomaLorenza Rimassa
Hepatobiliary Surgery and Nutrition|June 13, 2022
Hepatocellular carcinoma as the Rose of Jericho: from the desert of sorafenib, to the blossoming of immunotherapyAntonio D'Alessio, Lorenza Rimassa
Journal of Oncology Practice|June 13, 2017
Hepatocellular Carcinoma: A Global Disease in Need of Individualized Treatment StrategiesNicola Personeni, Lorenza Rimassa
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Exploring novel avenues for neoadjuvant treatment of hepatocellular carcinomaNicola Personeni, Lorenza Rimassa
Med (New York, N.Y.)|March 15, 2025
A new standard for HCC: The high stakes of TACE-immunotherapy combinationsAntonio D'Alessio, Lorenza Rimassa
Med (New York, N.Y.)|January 13, 2024
The long and winding road: Adjuvant therapy for early-stage hepatocellular carcinomaAntonio D'Alessio, Lorenza Rimassa
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
The present and the future landscape of treatment of advanced hepatocellular carcinomaLorenza Rimassa, Armando Santoro
The Lancet. Oncology|June 8, 2018
Shaping the landscape of immune oncology in hepatocellular carcinomaNicola Personeni, Lorenza Rimassa
The Lancet. Oncology|May 30, 2021
Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinomaNicola Personeni, Lorenza Rimassa
Pageof 34

Showing results (1-10 of 338) with videos related to

Sort By:
Pageof 34
Cancers|October 23, 2020
Novel Therapies for Hepatocellular CarcinomaLorenza Rimassa
Gastroenterology & Hepatology|October 27, 2018
Drugs in Development for Hepatocellular CarcinomaLorenza Rimassa
Hepatobiliary Surgery and Nutrition|June 13, 2022
Hepatocellular carcinoma as the Rose of Jericho: from the desert of sorafenib, to the blossoming of immunotherapyAntonio D'Alessio, Lorenza Rimassa
Journal of Oncology Practice|June 13, 2017
Hepatocellular Carcinoma: A Global Disease in Need of Individualized Treatment StrategiesNicola Personeni, Lorenza Rimassa
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Exploring novel avenues for neoadjuvant treatment of hepatocellular carcinomaNicola Personeni, Lorenza Rimassa
Med (New York, N.Y.)|March 15, 2025
A new standard for HCC: The high stakes of TACE-immunotherapy combinationsAntonio D'Alessio, Lorenza Rimassa
Med (New York, N.Y.)|January 13, 2024
The long and winding road: Adjuvant therapy for early-stage hepatocellular carcinomaAntonio D'Alessio, Lorenza Rimassa
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
The present and the future landscape of treatment of advanced hepatocellular carcinomaLorenza Rimassa, Armando Santoro
The Lancet. Oncology|June 8, 2018
Shaping the landscape of immune oncology in hepatocellular carcinomaNicola Personeni, Lorenza Rimassa
The Lancet. Oncology|May 30, 2021
Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinomaNicola Personeni, Lorenza Rimassa
Pageof 34